Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSecure Trust Bank Regulatory News (STB)

Share Price Information for Secure Trust Bank (STB)

Share Price is delayed by 15 minutes
Get Live Data
1,332.00    0.00 (0.00%)
Bid:
1,334.00
Ask:
1,340.00
Spread: 6.00 (0.45%)
Market Cap: £249.54m
STB Live PriceLast checked at - London Stock Exchange

Intraday Secure Trust Bank Share Chart

Trading Update

15 Oct 2014 07:00

RNS Number : 3158U
Arbuthnot Banking Group PLC
15 October 2014
 



FOR IMMEDIATE RELEASE

15 October 2014

Arbuthnot Banking Group PLC

2014 Third Quarter Trading Update

Arbuthnot Banking Group PLC ("Arbuthnot" or the "Group") today issues an update of trading for the three months to 30 September 2014.

The Group has traded strongly in the third quarter with both banks seeing good demand for their products. As a result of the £75m institutional placing of Secure Trust Bank shares, which was completed on 9 July 2014, the capital base of the Group increased by more than 80%. All of this new capital is available to support growth.

Retail Banking

Secure Trust Bank (STB) has experienced strong demand for its consumer finance lending, especially in Cycle and Motor Finance. It also successfully launched its Season Ticket financing product and expects this to develop further in 2015.

 

The bank has made good progress with the development of its SME lending business. The Real Estate finance team has built up a significant pipeline of good quality opportunities with prudent loan to values. At the same time it has accelerated its recruitment plans adding to both relationship management and credit risk teams.

Secure Trust Bank Commercial Services, the invoice finance division of the bank, launched as planned on 1 September.

STB's total new lending volumes written during Q3 2014 are over 87% higher than in the same period last year. The loan book, which is now over £500 million, has performed consistently with the trends reported in the first six months of 2014. Impairment levels remain below those expected when the loans were originated.

Private Banking

The investment made by Arbuthnot Latham (AL) in its Private Banking distribution continues to be rewarded.

 

The bank has seen a good flow of new client introductions leading to attractive loan opportunities and further increases in funds under management.

The Dubai branch has celebrated its first anniversary and remains on track to break even in 2015 as planned.

The sale of certain assets of Gilliat Financial Solutions and its subsequent cessation of business were completed during the quarter, with no material impact on the profitability of AL.

Accordingly, the Group anticipates the full year results will be marginally ahead of market expectations. Given the improving market conditions and the enlarged capital base, the Group remains well positioned to maintain its positive progress. 

 

Note: Secure Trust Bank also today issued an update on trading for the same three month period. The two announcements should be read in conjunction with each other.

 

Enquiries:

Arbuthnot Banking Group 0207 012 2400

Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

David Marshall, Director of Communications

Canaccord Genuity Ltd (Nominated Advisor) 0207 665 4500

Sunil Duggal

Numis Securities Ltd (Broker) 0207 260 1000

Chris Wilkinson

Mark Lander

Bell Pottinger (Financial PR) 0203 772 2563

Ben Woodford

Zoe Pocock

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUSONRSVARAAA
Date   Source Headline
9th Jul 20254:18 pmRNSDirector/PDMR Shareholding
7th Jul 20253:51 pmRNSDirector/PDMR Shareholding
4th Jul 20251:59 pmRNSDirector/PDMR Shareholding
2nd Jul 20257:00 amRNSStrategic pivot to increase Group ROAE
1st Jul 20253:34 pmRNSTotal Voting Rights
17th Jun 20257:00 amRNSCEO Succession Plan
16th Jun 20253:00 pmRNSDirector/PDMR Shareholding
12th Jun 20257:30 amRNSNon-Executive Director Appointment
30th May 20254:02 pmRNSTotal Voting Rights
15th May 20254:58 pmRNSResult of 2025 AGM
15th May 20257:00 amRNSQ1 2025 Trading Update
25th Apr 20255:50 pmRNSDirector/PDMR Shareholding
24th Apr 202511:43 amRNSDirector/PDMR Shareholding
17th Apr 20258:30 amRNSDirector/PDMR Shareholding
8th Apr 20254:43 pmRNSDirector/PDMR Shareholding
4th Apr 202511:20 amRNSNotice of AGM
26th Mar 20253:01 pmRNSDirector/PDMR Shareholding
24th Mar 20254:48 pmRNSDirector/PDMR Shareholding
24th Mar 20254:47 pmRNSDirector/PDMR Shareholding
17th Mar 20252:48 pmRNSDirector/PDMR Shareholding
13th Mar 20253:56 pmRNSAnnual Financial Report
13th Mar 20257:00 amRNSFinal Results
11th Mar 20259:00 amRNSNotice of Retail Investor Webcast
14th Feb 20252:11 pmRNSHolding(s) in Company
7th Feb 202511:59 amRNSHolding(s) in Company
7th Feb 202511:38 amRNSHolding(s) in Company
3rd Feb 20251:34 pmRNSBlock listing Interim Review
16th Jan 202511:07 amRNSHolding(s) in Company
24th Dec 202411:18 amRNSHolding(s) in Company
23rd Dec 20242:36 pmRNSHolding(s) in Company
19th Dec 20244:28 pmRNSDirector Declaration
18th Dec 202411:44 amRNSHolding(s) in Company
13th Dec 20243:14 pmRNSAppointment of Remuneration Committee Chairman
6th Dec 20245:07 pmRNSHolding(s) in Company
2nd Dec 20241:47 pmRNSDirector/PDMR Shareholding
19th Nov 20244:19 pmRNSHolding(s) in Company
13th Nov 20244:50 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSCapital Markets Event
8th Nov 20241:15 pmRNSHolding(s) in Company
1st Nov 20243:51 pmRNSHolding(s) in Company
1st Nov 20243:15 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTrading Update
28th Oct 202412:14 pmRNSVehicle Finance Update
24th Oct 20247:30 amRNSNon-Executive Director Succession
16th Oct 20248:54 amRNSNotice of Capital Markets Event and Q3 Update
10th Oct 20244:37 pmRNSHolding(s) in Company
27th Sep 20243:37 pmRNSDirector/PDMR Shareholding
16th Sep 202411:31 amRNSDirector/PDMR Shareholding
2nd Sep 20248:30 amRNSTotal Voting Rights
21st Aug 20242:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.